دورية أكاديمية
أعرض في EDS

The historical progression of positron emission tomography research in neuroendocrinology.

التفاصيل البيبلوغرافية
العنوان: The historical progression of positron emission tomography research in neuroendocrinology.
المؤلفون: Bini J; Yale PET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, United States. Electronic address: jason.bini@yale.edu.
المصدر: Frontiers in neuroendocrinology [Front Neuroendocrinol] 2023 Jul; Vol. 70, pp. 101081. Date of Electronic Publication: 2023 Jul 07.
نوع المنشور: Systematic Review; Journal Article; Review; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 7513292 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6808 (Electronic) Linking ISSN: 00913022 NLM ISO Abbreviation: Front Neuroendocrinol Subsets: MEDLINE
أسماء مطبوعة: Publication: Orlando, FL : Academic Press
Original Publication: New York, Raven Press [etc.]
مواضيع طبية MeSH: Neuroendocrinology* , Positron-Emission Tomography*/methods, Humans ; Radiopharmaceuticals/metabolism ; Brain/diagnostic imaging ; Brain/metabolism
مستخلص: The rapid and continual development of a number of radiopharmaceuticals targeting different receptor, enzyme and small molecule systems has fostered Positron Emission Tomography (PET) imaging of endocrine system actions in vivo in the human brain for several decades. PET radioligands have been developed to measure changes that are regulated by hormone action (e.g., glucose metabolism, cerebral blood flow, dopamine receptors) and actions within endocrine organs or glands such as steroids (e.g., glucocorticoids receptors), hormones (e.g., estrogen, insulin), and enzymes (e.g., aromatase). This systematic review is targeted to the neuroendocrinology community that may be interested in learning about positron emission tomography (PET) imaging for use in their research. Covering neuroendocrine PET research over the past half century, researchers and clinicians will be able to answer the question of where future research may benefit from the strengths of PET imaging.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
References: Neuroimage. 2017 Jan 1;144(Pt A):101-112. (PMID: 27639359)
Acta Psychiatr Scand. 2020 Oct;142(4):294-306. (PMID: 33314049)
Nucl Med Biol. 2016 Aug;43(8):478-89. (PMID: 27236283)
Mol Psychiatry. 2013 Sep;18(9):1034-40. (PMID: 23670490)
Biol Psychiatry. 2020 Mar 15;87(6):570-576. (PMID: 31706582)
Psychoneuroendocrinology. 2008 May;33(4):517-29. (PMID: 18337016)
PLoS One. 2015 Jul 20;10(7):e0133621. (PMID: 26192187)
PLoS One. 2017 Oct 10;12(10):e0185926. (PMID: 29016679)
Psychiatry Res. 2008 Oct 30;164(1):77-80. (PMID: 18707852)
Nucl Med Biol. 2007 May;34(4):353-61. (PMID: 17499724)
Neurology. 2018 Apr 17;90(16):e1404-e1412. (PMID: 29661902)
Annu Rev Psychol. 2020 Jan 4;71:139-164. (PMID: 31561741)
Psychoneuroendocrinology. 2021 Nov;133:105381. (PMID: 34416504)
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2244-2252. (PMID: 29590401)
Sci Rep. 2017 Aug 14;7(1):8054. (PMID: 28808288)
Horm Metab Res. 2006 Jul;38(7):442-6. (PMID: 16933179)
Neuroimage. 2016 Apr 15;130:241-247. (PMID: 26876475)
Psychoneuroendocrinology. 2017 Feb;76:192-196. (PMID: 27951520)
Psychopharmacology (Berl). 2002 Dec;165(1):37-42. (PMID: 12474116)
Br J Psychiatry. 2007 Nov;191:387-92. (PMID: 17978317)
Neuroimage. 2011 Oct 15;58(4):1081-9. (PMID: 21801840)
Neuro Endocrinol Lett. 2008 Aug;29(4):467-74. (PMID: 18766152)
Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S215-21. (PMID: 14677082)
Neuroimage Clin. 2016 Aug 24;12:415-9. (PMID: 27622138)
Eur Neuropsychopharmacol. 2013 Apr;23(4):285-94. (PMID: 22732516)
Acta Pharm Sin B. 2019 Nov;9(6):1204-1215. (PMID: 31867166)
Psychoneuroendocrinology. 2017 Jul;81:22-28. (PMID: 28426945)
Diabetes. 2010 Sep;59(9):2171-7. (PMID: 20566663)
Neuroreport. 2008 Mar 5;19(4):431-5. (PMID: 18287941)
J Clin Endocrinol Metab. 1998 Dec;83(12):4498-505. (PMID: 9851799)
Neuroimage. 2008 Feb 15;39(4):1533-41. (PMID: 18077184)
Acta Diabetol. 2019 Feb;56(2):135-144. (PMID: 29959509)
Psychoneuroendocrinology. 2008 Nov;33(10):1419-25. (PMID: 18977091)
Neuroimage. 2007 Apr 1;35(2):511-7. (PMID: 17317222)
Neuroimage. 2014 May 15;92:182-92. (PMID: 24531046)
Biol Psychiatry. 2005 Feb 1;57(3):239-46. (PMID: 15691524)
J Cereb Blood Flow Metab. 2016 May;36(5):842-61. (PMID: 26945019)
Radiology. 2018 Jan;286(1):271-278. (PMID: 28846496)
J Am Coll Nutr. 2009 Dec;28(6):667-73. (PMID: 20516266)
J Neurosci. 2012 May 16;32(20):7074-81. (PMID: 22593075)
Mol Psychiatry. 2005 May;10(5):456-69. (PMID: 15724143)
Semin Nucl Med. 2023 Mar;53(2):213-229. (PMID: 36270830)
Bioorg Med Chem Lett. 2000 Apr 17;10(8):707-10. (PMID: 10782669)
EJNMMI Res. 2021 Mar 24;11(1):31. (PMID: 33761019)
J Neuroimmunol. 2013 Jul 15;260(1-2):28-36. (PMID: 23684123)
Biol Psychiatry. 1997 Feb 1;41(3):285-98. (PMID: 9024951)
Int J Neuropsychopharmacol. 2010 Oct;13(9):1129-43. (PMID: 20519060)
PLoS One. 2018 Dec 12;13(12):e0207885. (PMID: 30540774)
Psychopharmacology (Berl). 2010 Jan;208(1):109-19. (PMID: 19911168)
Synapse. 2013 Nov;67(11):748-56. (PMID: 23650017)
Front Neuroendocrinol. 2022 Oct;67:101033. (PMID: 36126747)
J Labelled Comp Radiopharm. 2017 Oct;60(12):556-565. (PMID: 28670707)
J Neurosci Res. 2020 Nov;98(11):2208-2218. (PMID: 32761874)
Psychoneuroendocrinology. 2014 Jul;45:1-10. (PMID: 24845171)
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):3009-3010. (PMID: 33730173)
J Nucl Med. 2021 May 10;62(5):723-731. (PMID: 32887758)
Diabetes. 2008 Feb;57(2):470-5. (PMID: 18003752)
Front Neurosci. 2020 Oct 19;14:565668. (PMID: 33192252)
World J Nucl Med. 2016 Jan-Apr;15(1):3-6. (PMID: 26912971)
Front Neuroendocrinol. 2018 Apr;49:8-30. (PMID: 29132949)
Neurobiol Aging. 2017 Sep;57:36-46. (PMID: 28599217)
Transl Psychiatry. 2022 Jun 14;12(1):248. (PMID: 35701411)
Cell Mol Life Sci. 2016 Feb;73(4):705-22. (PMID: 26521082)
Synapse. 2014 Jul;68(7):317-20. (PMID: 24573975)
Acta Psychiatr Scand. 2005 Oct;112(4):257-65. (PMID: 16156832)
J Nucl Med. 2018 Aug;59(8):1249-1254. (PMID: 29371405)
Neurobiol Aging. 2000 Mar-Apr;21(2):373-83. (PMID: 10867223)
Nucl Med Commun. 2020 Jun;41(6):526-532. (PMID: 32282630)
Trends Endocrinol Metab. 2018 Apr;29(4):218-237. (PMID: 29475578)
Clin Nucl Med. 2015 Aug;40(8):632-6. (PMID: 26018720)
Synapse. 2015 Apr;69(4):195-202. (PMID: 25664726)
Hum Reprod. 1996 Dec;11(12):2799-805. (PMID: 9021395)
Biol Psychiatry. 2015 Oct 15;78(8):534-43. (PMID: 26004162)
Arch Gen Psychiatry. 2010 May;67(5):468-74. (PMID: 20439828)
Front Aging Neurosci. 2016 May 24;8:108. (PMID: 27252647)
Psychoneuroendocrinology. 2011 Nov;36(10):1453-9. (PMID: 21549509)
PLoS One. 2017 Jul 17;12(7):e0181400. (PMID: 28715453)
Bioorg Med Chem Lett. 2013 Apr 1;23(7):2052-5. (PMID: 23465610)
Diabetes. 1992 Jul;41(7):855-60. (PMID: 1612200)
EJNMMI Phys. 2020 May 25;7(1):35. (PMID: 32451783)
Psychoneuroendocrinology. 2019 Feb;100:32-40. (PMID: 30273797)
J Neuroendocrinol. 2010 Aug;22(8):833-45. (PMID: 20553371)
Biol Psychiatry. 2001 Nov 1;50(9):668-76. (PMID: 11704073)
Psychoneuroendocrinology. 2014 Jan;39:74-87. (PMID: 24275006)
Hum Brain Mapp. 2000 Nov;11(3):162-77. (PMID: 11098795)
Biol Psychiatry. 2003 Nov 1;54(9):890-5. (PMID: 14573316)
J Neuropsychiatry Clin Neurosci. 2009 Spring;21(2):132-43. (PMID: 19622684)
J Nucl Med. 2014 Jun;55(6):976-82. (PMID: 24744444)
Nucl Med Biol. 2001 Feb;28(2):187-95. (PMID: 11295429)
Curr Psychiatry Rep. 2015 Oct;17(10):77. (PMID: 26272540)
Psychiatry Res. 2007 Aug 15;155(3):245-56. (PMID: 17587554)
Nucl Med Biol. 2014 Jul;41(6):524-35. (PMID: 24793011)
J Clin Endocrinol Metab. 2009 Aug;94(8):2922-9. (PMID: 19435829)
Psychiatry Res. 2009 Apr 30;172(1):31-7. (PMID: 19118985)
J Nucl Med. 2014 Mar;55(3):481-7. (PMID: 24481026)
J Neurochem. 2005 Feb;92(4):798-806. (PMID: 15686481)
PLoS One. 2019 Mar 8;14(3):e0212738. (PMID: 30849082)
Exp Physiol. 2014 Sep;99(9):1121-7. (PMID: 25210111)
Psychiatry Res. 2006 Dec 1;148(2-3):185-93. (PMID: 17085022)
Annu Rev Biomed Eng. 2019 Jun 4;21:551-581. (PMID: 31167104)
Neuroimage. 2019 Jan 1;184:834-842. (PMID: 30296558)
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8836-41. (PMID: 9238064)
Am J Psychiatry. 2007 Aug;164(8):1250-8. (PMID: 17671289)
Nucl Med Biol. 2021 Jan;92:72-77. (PMID: 33262001)
Psychoneuroendocrinology. 2020 Aug;118:104711. (PMID: 32460196)
Cereb Cortex. 2009 May;19(5):1167-74. (PMID: 18854582)
Psychiatry Res Neuroimaging. 2017 Sep 30;267:45-50. (PMID: 28738293)
Front Neurosci. 2014 Dec 08;8:388. (PMID: 25538545)
Diabetes. 1998 Sep;47(9):1444-50. (PMID: 9726233)
Neuroreport. 2011 May 11;22(7):326-30. (PMID: 21460751)
Neurobiol Aging. 2017 Oct;58:34-40. (PMID: 28692878)
Neuropsychopharmacology. 2011 Dec;36(13):2729-40. (PMID: 21849982)
Synapse. 1996 Feb;22(2):123-31. (PMID: 8787128)
Diabetes Care. 2012 May;35(5):1105-11. (PMID: 22432117)
Med Phys. 2022 Sep;49(9):5830-5840. (PMID: 35880541)
Diabetes. 2001 Aug;50(8):1911-7. (PMID: 11473055)
Psychogeriatrics. 2022 May;22(3):373-381. (PMID: 35293067)
Exp Clin Endocrinol Diabetes. 2001;109(5):302-4. (PMID: 11507655)
Brain Behav Immun. 2016 Nov;58:18-30. (PMID: 27039241)
Neuroimage. 2003 Aug;19(4):1709-15. (PMID: 12948725)
Am J Physiol. 1990 May;258(5 Pt 1):E805-12. (PMID: 2185663)
Front Neuroendocrinol. 2020 Apr;57:100838. (PMID: 32268180)
J Nucl Med. 2019 Aug;60(8):1140-1146. (PMID: 30877174)
Cell Metab. 2018 Apr 3;27(4):740-756. (PMID: 29617641)
J Neurosci. 2017 Aug 23;37(34):8284-8291. (PMID: 28747384)
Mini Rev Med Chem. 2008 Jun;8(7):728-39. (PMID: 18537728)
Mol Psychiatry. 2016 Feb;21(2):229-36. (PMID: 25600111)
J Neurosci. 2001 Jul 15;21(14):5304-10. (PMID: 11438606)
J Clin Endocrinol Metab. 2007 Nov;92(11):4107-14. (PMID: 17726086)
Front Psychol. 2019 Jan 11;9:2767. (PMID: 30687199)
Br J Psychiatry. 2019 Sep;215(3):519-527. (PMID: 30457060)
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):77-109. (PMID: 34245328)
Neuropsychopharmacology. 2007 Nov;32(11):2310-20. (PMID: 17342167)
J Diabetes Complications. 2016 Mar;30(2):281-6. (PMID: 26796431)
J Clin Endocrinol Metab. 2011 Nov;96(11):E1761-70. (PMID: 21865354)
Lancet. 2001 Feb 3;357(9253):354-7. (PMID: 11210998)
J Neurosci. 2012 Oct 31;32(44):15369-76. (PMID: 23115175)
Eur J Neurosci. 2003 Mar;17(6):1296-302. (PMID: 12670318)
Biol Psychiatry. 2015 Jan 15;77(2):196-202. (PMID: 23540907)
Neuroimage Clin. 2017 Nov 06;17:354-358. (PMID: 29159047)
J Neurogastroenterol Motil. 2018 Oct 1;24(4):512-527. (PMID: 30041284)
Psychoneuroendocrinology. 2014 Aug;46:52-63. (PMID: 24882158)
Diabetes. 2012 Mar;61(3):564-5. (PMID: 22354931)
Mol Psychiatry. 2014 Jan;19(1):69-75. (PMID: 23089633)
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4569-74. (PMID: 10200303)
Obes Res. 2001 Nov;9(11):676-84. (PMID: 11707534)
Psychiatry Res. 2001 Jul 1;107(1):11-8. (PMID: 11472860)
Front Endocrinol (Lausanne). 2022 Mar 11;13:799675. (PMID: 35360055)
Nucl Med Biol. 2002 Jan;29(1):73-82. (PMID: 11786278)
Neuroimage. 2009 Aug 1;47(1):28-35. (PMID: 19362153)
Sci Rep. 2021 Dec 8;11(1):23623. (PMID: 34880350)
Neuropsychopharmacology. 2005 Apr;30(4):821-32. (PMID: 15702139)
Endocrine. 2019 Apr;64(1):14-30. (PMID: 30875057)
J Nucl Med. 2017 Oct;58(10):1652-1658. (PMID: 28450560)
Cereb Cortex. 2018 Dec 1;28(12):4169-4178. (PMID: 29045584)
Mol Imaging. 2013 Nov-Dec;12(8):. (PMID: 24447618)
Am J Psychiatry. 2001 Feb;158(2):311-4. (PMID: 11156818)
Neuroendocrinology. 2011;94(1):84-8. (PMID: 21606641)
Mol Psychiatry. 2021 Jun;26(6):2038-2047. (PMID: 33420479)
Am J Physiol. 1979 Sep;237(3):E214-23. (PMID: 382871)
Sci Rep. 2020 Jan 28;10(1):1335. (PMID: 31992803)
Brain Res. 2018 Nov 1;1698:213-219. (PMID: 30144405)
Biol Psychiatry. 2007 Oct 15;62(8):847-55. (PMID: 17544382)
J Nucl Med. 2022 Apr;63(4):609-614. (PMID: 34385336)
Nucl Med Biol. 2013 Oct;40(7):919-25. (PMID: 23829932)
Diabetes. 2002 Dec;51(12):3384-90. (PMID: 12453890)
J Clin Endocrinol Metab. 1990 Dec;71(6):1602-10. (PMID: 2229317)
Steroids. 2003 Feb;68(2):177-91. (PMID: 12606009)
Life Sci. 2002 Aug 9;71(12):1361-70. (PMID: 12127157)
Synapse. 2007 Jul;61(7):540-6. (PMID: 17447254)
Neuroimage. 2021 Feb 1;226:117523. (PMID: 33144221)
Alzheimer Dis Assoc Disord. 2021 Apr-Jun 01;35(2):164-168. (PMID: 32520734)
Psychiatry Res. 1998 Jul 15;83(1):1-6. (PMID: 9754700)
Neuroimage. 2012 Mar;60(1):592-600. (PMID: 22206963)
J Cereb Blood Flow Metab. 2009 Nov;29(11):1790-5. (PMID: 19584889)
Mol Imaging Biol. 2020 Aug;22(4):1124-1131. (PMID: 32133575)
Cell Metab. 2016 Jul 12;24(1):31-40. (PMID: 27292605)
PLoS One. 2016 Sep 12;11(9):e0159538. (PMID: 27617751)
Clin Diabetes. 2018 Apr;36(2):168-173. (PMID: 29686456)
J Alzheimers Dis. 2016 May 4;53(2):573-81. (PMID: 27163809)
Am J Psychiatry. 2003 Aug;160(8):1522-4. (PMID: 12900319)
Front Neuroendocrinol. 2018 Jan;48:50-57. (PMID: 29042142)
Diabetes Care. 2013 Dec;36(12):4050-6. (PMID: 24130356)
Diabetes. 2008 Feb;57(2):325-31. (PMID: 17991759)
J Clin Psychiatry. 2010 Sep;71(9):1131-7. (PMID: 20361897)
Horm Behav. 1998 Oct;34(2):171-82. (PMID: 9799627)
Neuroendocrinology. 2005;81(1):31-40. (PMID: 15809510)
J Nucl Med. 2019 Mar;60(3):299-303. (PMID: 30733314)
Bioorg Med Chem. 2006 Jun 15;14(12):4029-34. (PMID: 16529935)
Diabetes. 2017 Dec;66(12):2964-2972. (PMID: 28970283)
Psychoneuroendocrinology. 2010 Jan;35(1):179-91. (PMID: 19362426)
PLoS One. 2016 Jul 22;11(7):e0157347. (PMID: 27448273)
Biol Psychiatry. 2000 Oct 15;48(8):854-60. (PMID: 11063980)
Steroids. 2008 Jan;73(1):69-76. (PMID: 17942130)
Cell Metab. 2019 Mar 5;29(3):695-706.e4. (PMID: 30595479)
Int J Rad Appl Instrum B. 1992 May;19(4):461-80. (PMID: 1526811)
Pharmacol Biochem Behav. 2002 Mar;71(3):431-47. (PMID: 11830178)
Bioorg Med Chem Lett. 2016 Jul 15;26(14):3370-3375. (PMID: 27209233)
J Cereb Blood Flow Metab. 2000 Mar;20(3):423-51. (PMID: 10724107)
Fertil Steril. 2003 Sep;80(3):554-9. (PMID: 12969697)
J Cereb Blood Flow Metab. 1995 Mar;15(2):301-11. (PMID: 7860663)
Neuroreport. 2007 Jan 22;18(2):171-4. (PMID: 17301684)
Mol Psychiatry. 2018 Apr;23(4):1066-1075. (PMID: 28416813)
J Cereb Blood Flow Metab. 2015 Aug;35(8):1313-22. (PMID: 25833345)
Neurology. 2017 Sep 26;89(13):1382-1390. (PMID: 28855400)
Biol Psychiatry. 2011 Feb 15;69(4):374-80. (PMID: 21092938)
Psychoneuroendocrinology. 2010 Oct;35(9):1311-20. (PMID: 20356681)
ACS Chem Neurosci. 2020 Jun 3;11(11):1673-1681. (PMID: 32356969)
Diabetes. 2021 Jun;70(6):1265-1277. (PMID: 33674408)
PET Clin. 2021 Oct;16(4):553-576. (PMID: 34537130)
Psychopharmacology (Berl). 2014 Jan;231(2):409-17. (PMID: 23954912)
Diabetes. 1999 Oct;48(10):1915-21. (PMID: 10512354)
Am J Psychiatry. 2000 Apr;157(4):635-7. (PMID: 10739428)
Trends Endocrinol Metab. 2001 Aug;12(6):273-6. (PMID: 11445445)
J Clin Endocrinol Metab. 1997 Oct;82(10):3251-9. (PMID: 9329348)
Int J Neuropsychopharmacol. 2022 Jan 12;25(1):36-45. (PMID: 34555145)
Pharmaceuticals (Basel). 2022 Dec 31;16(1):. (PMID: 36678558)
Curr Radiopharm. 2017;10(1):35-40. (PMID: 28034352)
J Nucl Med. 2006 May;47(5):885-95. (PMID: 16644760)
Synapse. 2006 Aug;60(2):124-31. (PMID: 16715491)
Pharmacol Rev. 1991 Dec;43(4):425-73. (PMID: 1775506)
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5111-4. (PMID: 26456805)
Neuroimage Clin. 2019;22:101765. (PMID: 30904824)
Obes Surg. 2010 Mar;20(3):369-74. (PMID: 19902317)
J Nucl Med. 2018 Jan;59(1):3-12. (PMID: 28935835)
Diabetes. 2000 May;49(5):838-46. (PMID: 10905495)
Psychiatry Res. 2014 Jul 30;223(1):28-36. (PMID: 24819305)
Obes Surg. 2021 Oct;31(10):4592-4606. (PMID: 34304378)
Neurobiol Aging. 2005 Feb;26(2):229-35. (PMID: 15582750)
Psychoneuroendocrinology. 2011 May;36(4):502-13. (PMID: 20810219)
Brain Sci. 2021 Dec 15;11(12):. (PMID: 34942949)
Psychoneuroendocrinology. 2005 Jun;30(5):461-82. (PMID: 15721058)
Curr Alzheimer Res. 2020;17(12):1126-1132. (PMID: 33167835)
Arch Sex Behav. 1999 Feb;28(1):1-21. (PMID: 10097801)
Diabet Med. 2014 Apr;31(4):382-92. (PMID: 24765675)
Psychosom Med. 2006 Nov-Dec;68(6):859-62. (PMID: 17079706)
Psychoneuroendocrinology. 2016 May;67:124-32. (PMID: 26894483)
Int J Obes (Lond). 2007 Mar;31(3):440-8. (PMID: 16819526)
Phys Med Biol. 2021 Mar 12;66(6):06RM01. (PMID: 33339012)
Mol Metab. 2022 Mar;57:101351. (PMID: 34626851)
Brain Res. 1996 Jun 3;723(1-2):23-8. (PMID: 8813378)
Neuroimage. 2013 Aug 1;76:178-82. (PMID: 23523775)
Diabetes. 2021 Sep;70(9):1929-1937. (PMID: 34176784)
Biol Psychiatry. 2008 Jan 15;63(2):234-40. (PMID: 17686466)
Stress. 2019 Jan;22(1):93-102. (PMID: 30369292)
Sci Pharm. 2013 Jul 01;81(3):625-39. (PMID: 24106662)
J Med Chem. 2002 Nov 21;45(24):5397-405. (PMID: 12431067)
Bioorg Med Chem. 2012 Feb 1;20(3):1337-45. (PMID: 22249122)
Front Neuroendocrinol. 2020 Jan;56:100817. (PMID: 31837339)
Surg Oncol Clin N Am. 2020 Apr;29(2):209-221. (PMID: 32151356)
Acta Med Austriaca. 2003;30(5):130-3. (PMID: 15055159)
J Clin Invest. 2021 Oct 15;131(20):. (PMID: 34651587)
Alzheimers Res Ther. 2017 Aug 17;9(1):64. (PMID: 28818092)
Am J Psychiatry. 1997 Feb;154(2):224-30. (PMID: 9016272)
Neurochem Res. 2009 Feb;34(2):234-7. (PMID: 18535904)
Neuroimage. 2010 Nov 1;53(2):584-92. (PMID: 20600990)
Diabetes. 2006 Nov;55(11):2986-92. (PMID: 17065334)
Neurology. 2020 Jul 14;95(2):e166-e178. (PMID: 32580974)
J Cereb Blood Flow Metab. 2020 Apr;40(4):695-704. (PMID: 30895878)
Psychiatry Res. 2004 Dec 30;132(3):197-207. (PMID: 15664791)
J Cereb Blood Flow Metab. 2012 Dec;32(12):2146-52. (PMID: 22929437)
Obesity (Silver Spring). 2017 Nov;25(11):1910-1915. (PMID: 28944597)
Am J Psychiatry. 2013 Mar;170(3):305-14. (PMID: 23361612)
Biol Psychiatry. 2015 Oct 15;78(8):525-33. (PMID: 25497691)
J Nucl Med. 2015 Jan;56(1):98-105. (PMID: 25525181)
Diabetes Care. 2021 Mar;44(3):788-794. (PMID: 33446523)
PLoS One. 2014 Mar 12;9(3):e89095. (PMID: 24622517)
Sci Rep. 2017 Dec 13;7(1):17490. (PMID: 29235507)
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22962-22966. (PMID: 32868418)
Sci Rep. 2017 Jul 24;7(1):6220. (PMID: 28740088)
J Nucl Med. 2020 Apr;61(4):570-576. (PMID: 31601695)
Neuroscience. 2009 Oct 6;163(2):640-5. (PMID: 19559762)
J Clin Endocrinol Metab. 2008 Aug;93(8):3208-14. (PMID: 18522979)
Elife. 2020 Nov 24;9:. (PMID: 33231171)
J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9. (PMID: 17519979)
Neuropsychopharmacology. 2016 Dec;41(13):3042-3050. (PMID: 27374277)
Stress. 2009 Nov;12(6):533-43. (PMID: 19658029)
Psychiatry Res. 2003 Oct 30;124(2):125-7. (PMID: 14561431)
ChemMedChem. 2020 Sep 3;15(17):1624-1628. (PMID: 32677155)
J Neurosci. 2006 May 24;26(21):5777-85. (PMID: 16723535)
Neuroimage. 2007 May 15;36(1):153-66. (PMID: 17433881)
Neuroimage. 2008 Jan 1;39(1):500-14. (PMID: 17913515)
Neuroimage. 2009 Sep;47(3):872-80. (PMID: 19501653)
Neurosci Lett. 2010 Jun 7;476(3):161-5. (PMID: 20399839)
معلومات مُعتمدة: K01 DK118005 United States DK NIDDK NIH HHS; UL1 TR001863 United States TR NCATS NIH HHS
فهرسة مساهمة: Keywords: Cerebral blood flow; Cortisol; Dopamine; Endocrinology; Estrogen; Glucose; Neuroendocrine; Positron emission tomography; Serotonin; Testosterone
المشرفين على المادة: 0 (Radiopharmaceuticals)
تواريخ الأحداث: Date Created: 20230709 Date Completed: 20230807 Latest Revision: 20240926
رمز التحديث: 20240926
مُعرف محوري في PubMed: PMC10530506
DOI: 10.1016/j.yfrne.2023.101081
PMID: 37423505
قاعدة البيانات: MEDLINE
الوصف
تدمد:1095-6808
DOI:10.1016/j.yfrne.2023.101081